SCHEMBL232675

SCHEMBL232675

CCC(C)CC(C)C(C)C

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20609977 0.88 PTPN1 (0.30) PTPN1
SCHEMBL28484019 0.85
SCHEMBL4654352 0.83
SCHEMBL19264937 0.81 PTPN1 (0.30) PTPN1
SCHEMBL21715721 0.81
SCHEMBL20610170 0.80 PTPN1 (0.32) PTPN1TSHR
SCHEMBL24736823 0.78
SCHEMBL38395 0.78
SCHEMBL15142390 0.78
SCHEMBL83545 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 323 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260062631-A1 CYCLOOCTANE CONTAINING FUEL COMPOSITIONS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2026-03-05 US claimed
US-20240326006-A1 GAS-TO-LIQUID REACTOR AND METHOD OF USING PLASMERICA LLC (US) 2024-10-03 US claimed
US-20240140888-A1 COMPOSITION COMPRISING AN ALKANE AND AN OXOESTER BIOSYNTHIS (FR) 2024-05-02 US claimed
CN-117843448-A Preparation method for safely and efficiently synthesizing isooctyl alcohol 新疆众合能源科技发展有限公司 2024-04-09 CN claimed
EP-4321651-A1 COMPOSITION COMPRISING AN ALKANE AND AN OXO ESTER Biosynthis (FR) 2024-02-14 EP claimed
US-20230312774-A1 Processes For Polymerizing Alpha-Olefins, Internal Olefins And Compositions Thereof ExxonMobil Technology and Engineering Company (US) 2023-10-05 US claimed
EP-3947606-A1 PROCESSES FOR POLYMERIZING ALPHA-OLEFINS, INTERNAL OLEFINS AND COMPOSITIONS THEREOF ExxonMobil Research and Engineering Company (US) 2022-02-09 EP claimed
CN-112666288-A Method for measuring volatile organic compounds in solid waste 江苏微谱检测技术有限公司 2021-04-16 CN claimed
WO-2020205708-A1 PROCESSES FOR POLYMERIZING ALPHA-OLEFINS, INTERNAL OLEFINS AND COMPOSITIONS THEREOF EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2020-10-08 WO claimed
US-20200308316-A1 PROCESSES FOR POLYMERIZING ALPHA-OLEFINS, INTERNAL OLEFINS AND COMPOSITIONS THEREOF EXXONMOBIL RES & ENG CO (US) 2020-10-01 US claimed
US-10737235-B2 Gas-to-liquid reactor and method of using PLASMERICA, LLC (US) 2020-08-11 US claimed
US-20180243721-A1 GAS-TO-LIQUID REACTOR AND METHOD OF USING PLASMERICA, LLC 2018-08-30 US claimed
EP-2829555-B1 METHOD FOR PRODUCING OLEFIN POLYMER MITSUI CHEMICALS INC (JP) 2018-05-16 EP claimed
WO-2017040704-A1 GAS-TO-LIQUID REACTOR AND METHOD OF USING PLASMERICA, LLC (US) 2017-03-09 WO claimed
CN-104203993-B Process for producing olefin polymer 三井化学株式会社 2016-06-15 CN claimed
US-9315602-B2 Method for producing olefin polymer MITSUI CHEMICALS, INC. (JP) 2016-04-19 US claimed
US-12616728-B2 Processes and systems for converting cannabinoids into cannabinoid derivatives and isolating the same SUPER CRITICAL IP, LLC (US) 2026-05-05 US disclosed
US-20260062631-A1 CYCLOOCTANE CONTAINING FUEL COMPOSITIONS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2026-03-05 US disclosed
US-4502950-A MIXING WITH SILICA OR SILICATE NIPPON OIL CO., LTD. (JP) 1985-03-05 US disclosed
EP-0086576-A1 Process for the solvent deasphalting of asphaltene-containing hydrocarbons NIPPON OIL CO. LTD. (JP) 1983-08-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12616728-B2 Processes and systems for converting cannabinoids into cannabinoid derivatives and isolating the same CNR2, CNR1, SCD PTPN1 4121/4885TSHR 2794/4885
US-20240140888-A1 COMPOSITION COMPRISING AN ALKANE AND AN OXOESTER ALKBH2, ABHD12, FAAH2 PTPN1 2991/4885TSHR 3034/4885
US-20260062631-A1 CYCLOOCTANE CONTAINING FUEL COMPOSITIONS CPT1A, CPT2, CNR2 PTPN1 4764/4885TSHR 3620/4885
US-20180243721-A1 GAS-TO-LIQUID REACTOR AND METHOD OF USING VEGFA, FLT1, KDR PTPN1 4748/4885TSHR 2854/4885
US-20230312774-A1 Processes For Polymerizing Alpha-Olefins, Internal Olefins And Compositions Thereof PUF60, CPT1A, YIF1A PTPN1 4867/4885TSHR 4810/4885
US-20240326006-A1 GAS-TO-LIQUID REACTOR AND METHOD OF USING VEGFA, FLT1, KDR PTPN1 4748/4885TSHR 2854/4885
US-10737235-B2 Gas-to-liquid reactor and method of using VEGFA, FLT1, KDR PTPN1 4748/4885TSHR 2854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.